Trial Search Results

Genetic Basis of Rosacea Study (Control)

Rosacea is a common disease characterized by inflammation and vascular abnormalities of the facial skin and ocular surface. It it considered to be a syndrome encompassing various combinations of cutaneous signs including flushing, erythema, telangiectasia, papules, edema, ocular lesions, and rhinophyma. The exact etiology of cutaneous rosacea is unknown but is characterized by persistent vasodilation, increased vascular permeability, and vascular hyper-reactivity of the microcirculation of the central part of the face. The purpose of this study is to develop gene expression profiles of papulopustular rosacea compared to those of normal skin. The investigator hopes to better understand the abnormal gene functions that might contribute to this condition. This understanding may lead to the development of additional and better treatments for rosacea.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Other: Skin Biopsy




Inclusion criteria include:

   1. Fitzpatrick skin type II or III

   2. Age greater than or equal to 18 years

   3. Individuals without a history of rosacea

Exclusion criteria include:

   1. Women who are pregnant or lactating

   2. Use of topical prescription medications or procedures to the face within one month of

   3. Skin conditions that might interfere with interpretation of procedure results (at the
   discretion of the investigator)

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Anne Chang, MD